Skip to main content
Log in

Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale

Recent studies have shown that pharmacological inhibition of the 12-lipoxygenase pathway selectively blocks opioid inhibition of GABAergic synaptic currents. A similar mechanism has been shown for the regulation of glutamate release in the ventral tegmental area (VTA) during acute withdrawal from morphine, although the functional significance of these effects in vivo are not known.

Objectives

We have utilized mice with a disruption of the "leukocyte-type" 12-lipoxygenase gene (12-LO−/− mice) to examine a variety of general behavioral responses as well as several specific responses to morphine and cocaine.

Methods

Behavioral responses to morphine include sensitivity to thermal stimuli and withdrawal from chronic morphine treatment. Responses to cocaine were measured through locomotor activity.

Results

General behavioral responses in 12-LO−/− mice are not different from their wild-type controls. However, these mutant mice showed enhanced morphine-induced analgesia. However, this effect is eliminated following chronic morphine treatment. In addition, 12-LO−/− mice demonstrated enhanced somatic signs of opiate withdrawal relative to littermate controls. Lastly, cocaine-mediated increases in locomotor activity was augmented acutely but not chronically in 12-LO−/− mice.

Conclusions

Together, these results suggest a role for metabolites of arachidonic acid metabolism in morphine- and cocaine-induced behavioral responses and may reflect a utilization of this pathway following acute but not chronic drug administration.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2A, B.
Fig. 3.
Fig. 4.

Similar content being viewed by others

References

  • Basbaum AI, Fields HL (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu Rev Neurosci 7:309–338

    CAS  PubMed  Google Scholar 

  • Bozarth MA, Wise RA (1984) Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science 224:516–517

    CAS  PubMed  Google Scholar 

  • Cameron DL, Williams JT (1993) Dopamine D1 receptors facilitate transmitter release. Nature 366:344–347

    Google Scholar 

  • Chieng B, Christie MJ (1994) Hyperpolarization by opioids acting on μ-receptors of a subpopulation of rat periaqueductal gray neurons in vitro. Br J Pharmacol 113:121–128

    CAS  PubMed  Google Scholar 

  • Chieng B, Christie MJ (1996) Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J Neurosci 16:7128–7136

    CAS  PubMed  Google Scholar 

  • Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159

    CAS  PubMed  Google Scholar 

  • Crawley JN, Paylor R (1997) A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones Behav 31:197–211

    Article  CAS  Google Scholar 

  • Fry JP, Herz A, Zieglgansberger W (1980) A demonstration of naloxone-precipitated opiate withdrawal on single neurons in the tolerant/dependent rat brain. Br J Pharmacol 68:585–592

    CAS  PubMed  Google Scholar 

  • Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ (1992) Regulation of cyclic AMP response element-binding protein (CREB) phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 58:1168–1171

    CAS  PubMed  Google Scholar 

  • Hedqvist P (1977) Basic mechanisms of prostaglandin action. Annu Rev Pharmac Tox 17:259–279

    CAS  Google Scholar 

  • Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ (1998) Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci 18:10269–10276

    CAS  PubMed  Google Scholar 

  • Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75–113

    CAS  PubMed  Google Scholar 

  • Kalivas PW, Stewart J (1991) Dopamine transmission in drug- and stress-induced behavioral sensitization. Brain Res Rev 16:223–244

    CAS  PubMed  Google Scholar 

  • Kalivas PW, Duffy P (1998) Repeated cocaine administration alters extracellular glutamate in the ventral tegmental area. J Neurochem 70:1497–1502

    CAS  PubMed  Google Scholar 

  • Kalivas PW, Duffy P, Eberhardt H (1990) Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J Pharmacol Exp Ther 253:858–866

    CAS  PubMed  Google Scholar 

  • Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186–191

    CAS  PubMed  Google Scholar 

  • Li J, Ning G, Duncan SA (2000) Mammalian hepatocyte differentiation requires the transcription factor HNF-4 alpha. Genes Dev 14:464–474

    CAS  PubMed  Google Scholar 

  • Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669–677

    CAS  PubMed  Google Scholar 

  • Mansour A, Fox CA, Akil H, Watson SJ (1995) Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci 18:22–29

    CAS  PubMed  Google Scholar 

  • Manzoni OJ, Williams JT (1999) Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal. J Neurosci 19:6629–6636

    CAS  PubMed  Google Scholar 

  • Matsuoka I, Maldonado R, Defer N, Noel F, Hanoune J, Roques BP (1994) Chronic morphine administration causes region-specific increase of brain type VIII adenylyl cyclase mRNA. Eur J Pharmacol 268:215–221

    Article  CAS  PubMed  Google Scholar 

  • Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2:119–128

    CAS  PubMed  Google Scholar 

  • Nestler EJ, Alreja M, Aghajanian GK (1994) Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus. Brain Res Bull 35:521–528

    CAS  PubMed  Google Scholar 

  • Nishiyama M, Watanabe T, Ueda N, Tsukamoto H, Watanabe K (1993) Arachidonate 12-lipoxygenase is localized in neurons, glial cells, and endothelial cells of the canine brain. J Histochem Cytochem 41:111–117

    CAS  PubMed  Google Scholar 

  • Piomelli D, Greengard P (1990) Lipoxygenase metabolites of arachidonic acid in neuronal transmembrane signalling. Trends Pharmacol Sci 11:367–373

    Article  CAS  PubMed  Google Scholar 

  • Piomelli D, Volterra A, Dale N, Siegelbaum SA, Kandel ER, Schwartz JH, Belardetti F (1987) Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature 328:38–43

    CAS  PubMed  Google Scholar 

  • Robinson TE, Becker JB (1986) Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 11:157–198

    CAS  Google Scholar 

  • Russell JA, Leng G, Bicknell RJ (1995) Opioid tolerance and dependence in the magnocellular oxytocin system: a physiological mechanism? Exp Physiol 80:207–340

    Google Scholar 

  • Shimizu T, Wolfe LS (1990) Arachidonic acid cascade and signal transduction. J Neurochem 55:1–13

    CAS  PubMed  Google Scholar 

  • Shinjo F, Yoshimoto T, Yokoyama C, Yamamoto S, Izumi S, Komatsu N, Watanabe K (1986) Studies on porcine arachidonate 12-lipoxygenase using its monoclonal antibodies. J Biol Chem 261:3377–3381

    CAS  PubMed  Google Scholar 

  • Stewart J, Badiani A (1993) Tolerance and sensitization to the behavioral effects of drugs. Behav Pharmacol 4:289–312

    CAS  PubMed  Google Scholar 

  • Sun D, Funk CD (1996) Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low-density lipoprotein. J Biol Chem 271:24055–24062

    Article  CAS  PubMed  Google Scholar 

  • Torrecilla M, Marker CL, Cintora SC, Stoffel M, Williams JT, Wickman K (2002) G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. J Neurosci 22:4328–4334

    CAS  PubMed  Google Scholar 

  • Vaughan CW, Christie MJ (1997) Presynaptic inhibitory action of opioids on synaptic transmission in the rat periaqueductal grey in vitro. J Physiol (Lond) 498:463–472

    Google Scholar 

  • Vaughan CW, Ingram SL, Connor MA, Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature 390:611–614

    Article  CAS  PubMed  Google Scholar 

  • Wise RA, Bozarth MA (1981) Brain substrates for reinforcement and drug self-administration. Prog Neuropsychopharmacol 5:467–474

    CAS  PubMed  Google Scholar 

  • Wolfe LS, Pappius HM (1984) Arachidonic acid metabolites in cerebral ischemia and brain injury. Elsevier, Amsterdam

Download references

Acknowledgement

This work was supported by National Institute on Drug Abuse Grant DA-11649–01A2.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julie A. Blendy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Walters, C.L., Wang, BC., Godfrey, M. et al. Augmented responses to morphine and cocaine in mice with a 12-lipoxygenase gene disruption. Psychopharmacology 170, 124–131 (2003). https://doi.org/10.1007/s00213-003-1526-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-003-1526-7

Keywords

Navigation